Recursion Pharmaceuticals, Inc. (RXRX)

NASDAQ: RXRX · Real-Time Price · USD

3.310

+0.020 (0.61%)

At close: Aug 13, 2026, 4:00 PM EDT

3.300

-0.010 (-0.30%)

After-hours: Aug 13, 2026, 7:54 PM EDT

Recursion Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,775	2,160	2,682	2,310	1,473	2,917
Market Cap Growth	-22.80%	-19.46%	16.13%	56.84%	-49.51%	-
Enterprise Value	1,296	1,495	2,197	1,969	973.88	2,401
Last Close Price	3.31	4.09	6.76	9.86	7.71	17.13

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	32.36	28.93	45.59	51.82	36.96	286.58
PB Ratio	1.94	1.91	2.59	4.98	3.03	5.37
P/TBV Ratio	3.57	2.78	3.37	5.47	2.80	3.97

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	23.63	20.02	37.33	44.17	24.44	235.89

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.06	0.06	0.09	0.10	0.09	0.00
Net Debt / Equity Ratio	-0.52	-0.59	-0.47	-0.74	-1.03	-0.95
Net Debt / EBITDA Ratio	1.03	1.18	1.10	1.05	2.13	2.96
Net Debt / FCF Ratio	1.36	1.76	1.30	1.14	4.14	2.60
Asset Turnover	0.04	0.05	0.06	0.07	0.06	0.02
Quick Ratio	4.67	5.20	3.43	4.24	5.51	11.27
Current Ratio	5.03	5.50	3.81	4.70	5.68	11.46
Return on Equity (ROE)	-50.73%	-59.54%	-61.90%	-69.12%	-46.56%	-47.51%
Return on Assets (ROA)	-40.14%	-44.34%	-45.46%	-51.04%	-37.47%	-40.22%
Return on Invested Capital (ROIC)	-122.75%	-127.75%	-142.33%	-631.89%	-3510.89%	-1876.25%
Return on Capital Employed (ROCE)	-44.97%	-50.10%	-52.59%	-60.27%	-42.20%	-43.56%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-41.13%	-63.18%	-31.92%	-18.41%	-40.04%	-475.48%
Total Shareholder Return	-41.13%	-63.18%	-31.92%	-18.41%	-40.04%	-475.48%

SEC Filings: 10-K · 10-Q